Carbamazepine
- Product NDC
- 0121-0947
- 11-digit product format
- 001210947
- Labeler code
- 0121
- Product ID
- 0121-0947_cff80ddc-2a16-7b93-e053-2995a90aed9e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbamazepine
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Pharamaceutical Associates, Inc.
- Application
- ANDA076729
- Marketing category
- ANDA
- Marketing start
- 2021-10-07
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 100 mg/5mL
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0121-0947-94 | 00121094794 | 3 TRAY in 1 CASE (0121-0947-94) > 10 CUP, UNIT-DOSE in 1 TRAY > 10 mL in 1 CUP, UNIT-DOSE (0121-0947-05) | 3 tray | 2021-10-07 | 0000-00-00 | No | No | Current |